You’re on our free ad-supported tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

Eli Lilly
Pharmaceuticals
Novo Nordisk
AstraZeneca
GSK
Sanofi
Abbott Labs
Johnson and Johnson
Topics

Advertisement

Eli Lilly

Share

Top Latest Popular

NewsNow Essentials. Better browsing, ads free. Just £48/yr. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Just £48/yr. Upgrade now!

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors? The Motley Fool 6h

The Motley Fool 6h

Amycretin Novo Nordisk

Eli Lilly’s retatrutide hits Phase III goals with FDA filing planned for 2027 Manufacturing Chemist 9h

Manufacturing Chemist 9h

Eli Lilly-backed Scribe Therapeutics climbs 67% after raising $128.7 million in an upsized IPO Mint 6h

Mint 6h

Viking Therapeutics Flotations/IPOs

Advertisement

Advertisement

With a little help from pharma friends: Psychedelics for psychiatric therapy The Economic Times 4h

The Economic Times 4h

Pharma Biotechnology

STAT Plus: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit STAT 2d

STAT 2d

Novo Nordisk sues GLP-1 rival Eli Lilly for misleading advertising Forbes 3d

Forbes 3d

Novo Nordisk Pharma

Advertisement

Advertisement

Latest

In the last 6 hours

With a little help from pharma friends: Psychedelics for psychiatric therapy The Economic Times 19:35 Fri, 24 Jul

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors? The Motley Fool 18:08 Fri, 24 Jul

Eli Lilly-backed Scribe Therapeutics climbs 67% after raising $128.7 million in an upsized IPO Mint 18:04 Fri, 24 Jul

Yesterday

Novo Nordisk Seeks Pause on Eli Lilly’s Weight Loss Drug Ads Bloomberg Law 15:33 Fri, 24 Jul

Eli Lilly’s retatrutide hits Phase III goals with FDA filing planned for 2027 Manufacturing Chemist 15:15 Fri, 24 Jul

Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads The Times of India 14:35 Fri, 24 Jul

Is AtaiBeckley (ATAI) A Bargain On Eli Lilly’s Takeover Deal? Simply Wall St 14:08 Fri, 24 Jul

This Billionaire Made $360 Million Selling His Psychedelic Company To Eli Lilly Forbes 11:15 Fri, 24 Jul

Eli Lilly Cleared Two More Trials For Its Next-Generation Obesity Drug. It Will Seek FDA Approval Next Year IBTimes (US) 11:00 Fri, 24 Jul

Eli Lilly (LLY) Stock Still Looks Cheap Following Its 407% Run Simply Wall St 10:05 Fri, 24 Jul

Advertisement

Advertisement

Advertisement

About our Eli Lilly news

Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Takeda Takeda
- Teva Teva
- Zoetis Zoetis